Sandip Kapadia is CFO at Harmony Biosciences Holdings, Inc. (HRMY). They have made 5 open-market trades across 2 companies since 2017, most recently 2026-01-26.
CIK 0001677141
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $90K since 2020, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRMY | SELL · 10b5-1 | 2026-01-26 | 2026-01-28 | $37.15 | $139K | +0.8% | -22.4% | -15.3% |
| HRMY | SELL · 10b5-1 | 2026-01-15 | 2026-01-20 | $35.92 | $753K | +0.5% | -5.4% | -18.7% |
| HRMY | SELL · 10b5-1 | 2025-12-05 | 2025-12-09 | $39.54 | $791K | -3.0% | -2.8% | -26.7% |
| HRMY | SELL · 10b5-1 | 2025-11-21 | 2025-11-25 | $35.00 | $120K | +11.0% | +8.7% | -23.4% |
| HRMY | SELL · 10b5-1 | 2025-08-15 | 2025-08-19 | $36.50 | $1.6M | +1.4% | -10.3% | -6.6% |
| HRMY | SELL · 10b5-1 | 2025-04-01 | 2025-04-03 | $32.52 | $430K | -2.1% | +2.0% | +9.4% |
| HRMY | SELL · 10b5-1 | 2025-01-27 | 2025-01-28 | $38.05 | $135K | -2.6% | -14.8% | -23.6% |
| HRMY | SELL · 10b5-1 | 2025-01-21 | 2025-01-23 | $40.18 | $1.0M | +2.6% | -10.1% | -23.9% |
| PASG | SELL · 10b5-1 | 2022-12-01 | 2022-12-02 | $1.19 | $6K | +0.0% | +29.6% | -1.6% |
| ICPT | SELL | 2021-01-05 | 2021-01-05 | $24.47 | $107K | -11.5% | +14.2% | -21.0% |
| ICPT | SELL | 2020-12-15 | 2020-12-16 | $32.78 | $116K | -19.7% | -10.0% | -24.5% |
| PASG | BUY | 2020-03-03 | 2020-03-03 | $18.00 | $90K | -23.6% | -25.3% | +7.9% |
| ICPT | SELL | 2017-10-02 | 2017-10-04 | $58.83 | $21K | -2.6% | -5.9% | -18.5% |
| ICPT | SELL | 2017-07-03 | 2017-07-05 | $121.59 | $348K | +1.6% | -12.9% | -46.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.